Literature DB >> 17633937

The use of radioiodine in the management of benign thyroid disease.

Tony Weetman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17633937      PMCID： PMC4952692          DOI： 10.7861/clinmedicine.7-3-214

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  3 in total

1.  EANM procedure guidelines for therapy of benign thyroid disease.

Authors:  Marcel P M Stokkel; Daria Handkiewicz Junak; Michael Lassmann; Markus Dietlein; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

2.  Predictors of treatment failure, incipient hypothyroidism, and weight gain following radioiodine therapy for Graves' thyrotoxicosis.

Authors:  F W Gibb; N N Zammitt; G J Beckett; M W J Strachan
Journal:  J Endocrinol Invest       Date:  2013-04-30       Impact factor: 4.256

3.  Thyrotoxicosis and radioiodine therapy: Does the dose matter?

Authors:  Andrew Collier
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.